17-17793779-CCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_030665.4(RAI1):​c.858_872delGCAGCAGCAGCAGCA​(p.Gln287_Gln291del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000477 in 1,356,808 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00070 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00046 ( 0 hom. )

Consequence

RAI1
NM_030665.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.86

Publications

8 publications found
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]
RAI1 Gene-Disease associations (from GenCC):
  • Smith-Magenis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Potocki-Lupski syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_030665.4
BP6
Variant 17-17793779-CCAGCAGCAGCAGCAG-C is Benign according to our data. Variant chr17-17793779-CCAGCAGCAGCAGCAG-C is described in ClinVar as Likely_benign. ClinVar VariationId is 588823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000697 (55/78922) while in subpopulation SAS AF = 0.00367 (3/818). AF 95% confidence interval is 0.000999. There are 0 homozygotes in GnomAd4. There are 21 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 55 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAI1NM_030665.4 linkc.858_872delGCAGCAGCAGCAGCA p.Gln287_Gln291del disruptive_inframe_deletion Exon 3 of 6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkc.858_872delGCAGCAGCAGCAGCA p.Gln287_Gln291del disruptive_inframe_deletion Exon 3 of 6 1 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1
RAI1ENST00000395774.1 linkc.858_872delGCAGCAGCAGCAGCA p.Gln287_Gln291del disruptive_inframe_deletion Exon 2 of 2 2 ENSP00000379120.1 A8MXE8

Frequencies

GnomAD3 genomes
AF:
0.000698
AC:
55
AN:
78832
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00114
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000170
Gnomad ASJ
AF:
0.000508
Gnomad EAS
AF:
0.00133
Gnomad SAS
AF:
0.00368
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000579
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000463
AC:
592
AN:
1277886
Hom.:
0
AF XY:
0.000464
AC XY:
293
AN XY:
632002
show subpopulations
African (AFR)
AF:
0.000454
AC:
13
AN:
28606
American (AMR)
AF:
0.0000631
AC:
2
AN:
31686
Ashkenazi Jewish (ASJ)
AF:
0.000688
AC:
16
AN:
23268
East Asian (EAS)
AF:
0.000322
AC:
6
AN:
18624
South Asian (SAS)
AF:
0.00109
AC:
61
AN:
55802
European-Finnish (FIN)
AF:
0.000325
AC:
15
AN:
46138
Middle Eastern (MID)
AF:
0.00370
AC:
18
AN:
4864
European-Non Finnish (NFE)
AF:
0.000427
AC:
434
AN:
1016976
Other (OTH)
AF:
0.000520
AC:
27
AN:
51922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000697
AC:
55
AN:
78922
Hom.:
0
Cov.:
0
AF XY:
0.000560
AC XY:
21
AN XY:
37510
show subpopulations
African (AFR)
AF:
0.00113
AC:
27
AN:
23834
American (AMR)
AF:
0.000170
AC:
1
AN:
5874
Ashkenazi Jewish (ASJ)
AF:
0.000508
AC:
1
AN:
1968
East Asian (EAS)
AF:
0.00134
AC:
1
AN:
748
South Asian (SAS)
AF:
0.00367
AC:
3
AN:
818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6066
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
166
European-Non Finnish (NFE)
AF:
0.000579
AC:
22
AN:
37988
Other (OTH)
AF:
0.00
AC:
0
AN:
1080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00126
Hom.:
2

ClinVar

Significance: Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RAI1: BS1 -

Jan 24, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 26, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RAI1-related disorder Benign:1
Apr 02, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.9
Mutation Taster
=149/51
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371983878; hg19: chr17-17697093; API